1241786

Novartis Pharma AG — FEI 3014747778

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 4, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Basel (Switzerland)

Additional Details

Sponsor, Contract Research Organization